Related Experiment Video
Updated: Jun 4, 2026

Assessment of Oxidative Damage in the Primary Mouse Ocular Surface Cells/Stem Cells in Response to Ultraviolet-C (UV-C) Damage
Published on: February 15, 2020
UVA1 radiation inhibits calcineurin through oxidative damage mediated by photosensitization
Ruben E A Musson1, Paul J Hensbergen, Adrie H Westphal
1Department of Clinical Chemistry, Leiden University Medical Center, Leiden, The Netherlands. r.e.a.musson@lumc.nl
Abstract:
The protein phosphatase calcineurin has been gradually revealing itself as the central controller of our immune response, although it is involved in a wide array of signaling pathways related to cellular development and cell cycle progression. As such, calcineurin is an attractive, yet delicate, therapeutic target for the prevention of allograft rejection and treatment of several inflammatory skin conditions. However, calcineurin activity is not only sensitive to immunosuppressants such as cyclosporin A and tacrolimus, but also subject to modulation by reactive oxygen species. We have recently shown, both in vivo and in vitro, that UVA1 radiation suppresses calcineurin activity. In this paper, we present evidence that this activity loss is due to singlet oxygen and superoxide generated by photosensitization and show that a closely related phosphatase, PP2A, is not affected. Furthermore, a survey of this damage reveals oxidation of several Met and Cys residues as well as an overall conformational change. These findings provide a mechanistic basis for the hypothesis that UVA1 and calcineurin inhibitors both affect the same signal transduction pathway in skin.
Insights
UVA1 radiation suppresses calcineurin activity by generating reactive oxygen species, offering a new understanding of skin signaling pathways. This finding links UVA1 effects to calcineurin inhibitors used therapeutically.
Area of Science:
- Immunology
- Dermatology
- Biochemistry
Background:
- Calcineurin is a key regulator of immune response, cellular development, and cell cycle.
- It is a therapeutic target for allograft rejection and inflammatory skin conditions.
- Calcineurin activity is modulated by reactive oxygen species and immunosuppressants.
Purpose of the Study:
- To investigate the mechanism by which UVA1 radiation suppresses calcineurin activity.
- To determine if other phosphatases are affected by UVA1 radiation.
- To elucidate the molecular changes in calcineurin induced by UVA1.
Main Methods:
- In vivo and in vitro experiments were conducted.
- Reactive oxygen species (singlet oxygen and superoxide) were identified as mediators.
- Protein phosphatase 2A (PP2A) was used as a control.
- Mass spectrometry was used to analyze protein oxidation and conformational changes.
Main Results:
- UVA1 radiation significantly suppresses calcineurin activity.
- This suppression is mediated by singlet oxygen and superoxide generated via photosensitization.
- PP2A activity remains unaffected.
- Oxidation of methionine and cysteine residues and conformational changes in calcineurin were observed.
Conclusions:
- UVA1 radiation inhibits calcineurin activity through oxidative damage.
- The findings provide a mechanistic link between UVA1 radiation and calcineurin inhibitors.
- This suggests a shared signaling pathway in skin affected by both UVA1 and calcineurin inhibitors.
Related Concept Videos
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Biological Effects of Radiation
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
